Caption Management, LLC Rubius Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

  • $6.13 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$9.68 - $17.74 $454,960 - $833,779
-47,000 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$17.6 - $25.91 $52,800 - $77,730
-3,000 Reduced 6.0%
47,000 $840,000
Q2 2021

Aug 16, 2021
SELL
$22.26 - $28.43 $801,360 - $1.02 Million
-36,000 Reduced 41.86%
50,000 $1.22 Million
Q4 2020

Feb 16, 2021
BUY
$4.23 - $8.73 $363,780 - $750,780
86,000 New
86,000 $652,000

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email